- Home
- IMNM vs ELMD Comparison
IMNM vs ELMD Comparison
Compare IMNM & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMNM | ELMD |
|---|---|---|
| Founded | 2006 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 199.2M |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | IMNM | ELMD |
|---|---|---|
| Price | $19.45 | $24.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | $32.80 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 1.1M | 38.7K |
| Earning Date | 03-03-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.40 | 46.55 |
| EPS | N/A | ★ 0.56 |
| Revenue | $6,941,000.00 | ★ $54,716,000.00 |
| Revenue This Year | N/A | $15.59 |
| Revenue Next Year | $1,127.34 | $11.51 |
| P/E Ratio | ★ N/A | $43.66 |
| Revenue Growth | N/A | ★ 13.83 |
| 52 Week Low | $5.15 | $17.73 |
| 52 Week High | $27.65 | $30.73 |
Technical Indicators
Market Signals| Indicator | IMNM | ELMD |
|---|---|---|
| Relative Strength Index (RSI) | 36.87 | 50.72 |
| Support Level | $19.26 | $23.32 |
| Resistance Level | $22.57 | $25.38 |
| Average True Range (ATR) | 1.05 | 0.77 |
| MACD | -0.04 | 0.25 |
| Stochastic Oscillator | 1.41 | 78.79 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.